2026年全球即時檢測（POC​​）免疫檢測分析儀市場報告

近年來，即時檢測（POC​​）免疫檢測分析儀的市場規模持續強勁成長。預計該市場規模將從2025年的49億美元成長至2026年的53.1億美元，複合年成長率（CAGR）為8.6%。這一成長主要歸因於感染疾病疫情的蔓延、醫院檢查室基礎設施的進步、對快速診斷需求的不斷成長、免疫檢測技術的日益普及以及抗體和抗原檢測方法的改進。

預計未來幾年，即時檢測（POC​​）免疫檢測市場將保持強勁成長，到2030年市場規模將達到74.5億美元，複合年成長率（CAGR）為8.8%。推動預測期內市場成長的因素包括：個人化醫療和基於生物標記的檢測的擴展、醫療服務分散化趨勢的加速發展、人工智慧診斷系統的日益普及、居家醫療監測的興起以及快速診斷設備法規核准的增加。預測期內的關鍵趨勢包括：分散式即時診斷生態系統的擴展、多條帶免疫檢測平台的廣泛應用、攜帶式分析儀無線連接功能的整合、基於試劑盒的快速檢測系統的發展以及對家庭免疫診斷解決方案日益成長的需求。

感染疾病率的上升預計將推動即時免疫檢測分析儀市場的擴張。感染疾病是由細菌、病毒、寄生蟲和真菌等致病微生物引起的疾病，這些微生物可透過直接或間接途徑在人與人之間傳播。全球人口密度的增加加劇了感染疾病病率的上升，加速了感染風險和疾病傳播。即時（POC）免疫檢測分析儀的普及將透過快速、準確和分散地檢測感染疾病標記來支持感染疾病管理，從而加強早期診斷和疾病控制工作。例如，根據英國英國的數據，截至2025年3月，英格蘭的結核病病例數在2024年增加了13%，從2023年的4,850例增加到5,480例。因此，感染疾病率的上升正在推動即時免疫檢測分析儀市場的擴張。

在即時免疫檢測分析儀市場領先的企業正致力於開發創新解決方案，包括推進免疫檢測技術的進步，以滿足在緊急情況、偏遠地區、分散式醫療以及即時臨床決策中對快速診斷日益成長的需求。這些先進的免疫檢測分析儀是緊湊型診斷平台，利用抗原-抗體反應以高靈敏度檢測生物標記物，具有快速報告結果、便攜、樣本製備簡便以及多參數檢測等優勢。與需要複雜基礎設施和漫長處理時間的傳統集中式檢查室分析儀不同，即時檢測系統可在患者身邊進行檢測，提供更快的結果和更高的可及性。例如，安博生技公司於2023年7月推出了AF-100S螢光免疫分析法分析儀。該系統是一款緊湊型自動化螢光免疫分析法，專為快速定量檢測全血、血清和血漿等臨床檢體中的生物標記而開發。透過將基於螢光的檢測技術與自動校準和整合品管功能相結合，該系統確保了與集中式檢查室系統相媲美的高靈敏度和準確性。此外，該分析儀具有使用者友善的介面，可在幾分鐘內提供測試結果，因此非常適合急診、診所和分散式醫療保健環境。

目錄

第1章：執行摘要

第2章 市場特徵

• 市場定義和範圍
• 市場區隔
• 主要產品和服務概述
• 全球即時檢測（POC​​）免疫檢測分析儀市場：吸引力評分與分析
• 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

• 供應鏈與生態系概述
• 清單：主要原料、資源和供應商
• 主要經銷商和通路合作夥伴名單
• 主要最終用戶列表

第4章：全球市場趨勢與策略

• 關鍵科技與未來趨勢
  • 生物技術、基因組學和精準醫療
  • 人工智慧和自主智慧
  • 物聯網、智慧基礎設施、互聯生態系統
  • 數位化、雲端運算、巨量資料、網路安全
  • 工業4.0和智慧製造
• 主要趨勢
  • 擴展去中心化的即時診斷生態系統
  • 多重免疫檢測平台的應用日益廣泛
  • 將無線連接整合到可攜式分析儀中
  • 卡式快速檢測系統的發展
  • 家用免疫測定溶液的需求日益成長

第5章 終端用戶產業市場分析

• 醫院
• 診斷檢查室
• 居家醫療
• 學術研究機構
• 其他最終用戶

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

• 全球即時檢測（POC​​）免疫檢測分析儀市場：PESTEL 分析
• 全球即時檢測（POC​​）免疫檢測市場：規模、對比及成長率分析
• 全球即時檢測（POC​​）免疫檢測分析儀市場表現：規模與成長，2020-2025年
• 全球即時檢測（POC​​）免疫檢測分析儀市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

• 依產品類型
• 可攜式分析儀、桌上型分析儀、微流體分析儀
• 透過技術
• 化學冷光檢測、酵素免疫分析法、橫向流動化驗
• 依樣本類型
• 血液、尿液、唾液
• 透過使用
• 感染疾病、荷爾蒙檢測、自體免疫疾病、心臟標記、腫瘤學
• 最終用戶
• 醫院、診斷檢驗實驗室、居家照護機構、學術研究機構
• 細分（按類型）：可攜式分析儀
• 手持式免疫檢測、電池供電診斷設備、無線連接可攜式分析儀、單項檢測可攜式分析儀、多參數可攜式分析儀
• 細分（按類型）：桌上型分析儀
• 緊湊型實驗室桌上型分析儀、高通量桌上型分析儀、全自動桌上型分析儀、半自動桌上型分析儀、多功能桌上型系統
• 按類型細分：微流體分析儀
• 晶片實驗室分析儀、盒式微微流體控分析儀、連續流微流體系統、液滴式微微流體分析儀、整合微流體診斷系統

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

• 即時檢測（POC​​）免疫檢測分析儀市場：競爭格局與市場佔有率，2024年
• 即時檢測（POC​​）免疫檢測分析儀市場：公司估值矩陣
• 即時檢測（POC​​）免疫檢測分析儀市場：公司概況
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation

第37章 其他大型企業和創新企業

• Becton Dickinson and Company（BD）, Beckman Coulter, Bruker Corporation, BioRad Laboratories, Qiagen NV, Diasorin, Lepu Medical Technology, SD Biosensor, Eiken Chemical Co. Ltd., Molbio Diagnostics Pvt. Ltd., Maccura Biotechnology Co. Ltd., QuantuMDx Group Ltd., Ustar Biotechnologies Ltd., Mylab Discovery Solutions Pvt Ltd., Akonni Biosystems Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

• 即時檢測（POC​​）免疫檢測分析儀市場，2030 年：提供新機會的國家
• 即時檢測（POC​​）免疫檢測分析儀市場，2030 年：提供新機會的細分市場
• 即時檢測（POC​​）免疫檢測分析儀市場，2030 年：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第42章附錄

Point-of-care immunoassay analyzer expansion refers to the advancement, manufacturing, and adoption of point-of-care immunoassay analyzers for rapid diagnostic testing near the patient. These analyzers utilize immunoassay methods to identify specific proteins, hormones, antigens, or antibodies in biological samples such as blood, urine, or saliva, delivering quick and reliable results to support clinical decision-making.

The primary product types of point of care immunoassay analyzer expansion include portable analyzers, benchtop analyzers, and microfluidic analyzers. Portable analyzers refer to compact diagnostic devices developed for rapid immunoassay testing at or near the patient location, supporting quick clinical decision-making. These solutions are based on technologies such as chemiluminescence, enzyme-linked immunosorbent assay, and lateral flow assay and they utilize sample types including blood, urine, and saliva. The applications involved are infectious diseases, hormonal testing, autoimmune disorders, cardiac markers, and oncology, while the end-use includes hospitals, diagnostic laboratories, home care settings, and academic research institutions.

Tariffs are influencing the point-of-care (poc) immunoassay analyzer expansion market by increasing the cost of imported diagnostic instruments, reagents, microfluidic cartridges, and semiconductor-based components essential for analyzer production. This is slowing the deployment of portable, benchtop, and microfluidic systems, particularly in import-dependent regions such as Asia-Pacific and Latin America, where healthcare infrastructure expansion depends heavily on international suppliers. Hardware-intensive segments such as fully automated benchtop analyzers and cartridge-based microfluidic systems are most impacted due to complex cross-border supply chains. However, tariffs are also driving localization of manufacturing, strengthening regional supply ecosystems, and encouraging domestic production of diagnostic equipment, ultimately improving long-term supply chain resilience and market stability.

The point of care (POC) immunoassay analyzer expansion market research report is one of a series of new reports from The Business Research Company that provides point of care (POC) immunoassay analyzer expansion market statistics, including point of care (POC) immunoassay analyzer expansion industry global market size, regional shares, competitors with a point of care (POC) immunoassay analyzer expansion market share, detailed point of care (POC) immunoassay analyzer expansion market segments, market trends and opportunities, and any further data you may need to thrive in the point of care (POC) immunoassay analyzer expansion industry. This point of care (POC) immunoassay analyzer expansion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point of care (POC) immunoassay analyzer expansion market size has grown strongly in recent years. It will grow from $4.9 billion in 2025 to $5.31 billion in 2026 at a compound annual growth rate (CAGR) of 8.6%. The growth in the historic period can be attributed to rising prevalence of infectious diseases, growth of hospital laboratory infrastructure, increasing demand for rapid diagnostics, expansion of immunoassay technology adoption, improvements in antibody and antigen detection methods.

The point of care (POC) immunoassay analyzer expansion market size is expected to see strong growth in the next few years. It will grow to $7.45 billion by 2030 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to expansion of personalized medicine and biomarker-based testing, increasing shift toward decentralized healthcare delivery, rising adoption of ai-enabled diagnostic systems, growth in home-based healthcare monitoring, increasing regulatory approvals for rapid diagnostic devices. Major trends in the forecast period include expansion of decentralized point-of-care diagnostic ecosystems, increasing adoption of multiplex immunoassay platforms, integration of wireless connectivity in portable analyzers, growth of cartridge-based rapid testing systems, rising demand for at-home immunodiagnostic solutions.

The increasing prevalence of infectious diseases is expected to propel the growth of the point of care immunoassay analyzer expansion market going forward. Infectious diseases are medical conditions caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi that spread directly or indirectly between individuals. The increasing prevalence of infectious diseases is driven by rising global population density, which accelerates transmission risks and the spread of diseases. Point of care (POC) immunoassay analyzer expansion supports the management of infectious diseases by enabling rapid, accurate, and decentralized detection of infectious biomarkers, thereby strengthening early diagnosis and disease control efforts. For instance, in March 2025, according to the UK Health Security Agency, a UK-based government health authority, tuberculosis cases in England increased by 13% in 2024, reaching 5,480 cases compared to 4,850 cases in 2023. Therefore, the increasing prevalence of infectious diseases is driving the growth of the point of care immunoassay analyzer expansion market.

Leading companies operating in the point of care immunoassay analyser expansion market are concentrating on developing innovative solutions, such as advancements in immunoassay technologies, to address the growing demand for rapid diagnostics, decentralized healthcare, and real-time clinical decision-making in emergency and remote settings. These advanced immunoassay analyzers are compact diagnostic platforms that use antigen-antibody reactions to detect biomarkers with high sensitivity, offering capabilities such as rapid turnaround times, portability, minimal sample preparation, and multiplex testing functions; unlike conventional centralized laboratory analyzers that require sophisticated infrastructure and longer processing durations, POC systems facilitate near-patient testing with faster results and greater accessibility. For instance, in July 2023, Anbio Biotechnology launched the AF-100S Fluorescence Immunoassay Analyzer. This system is a compact, automated fluorescent immunoassay analyzer developed for rapid quantitative detection of biomarkers in clinical samples such as whole blood, serum, and plasma. It combines fluorescence-based detection technology with automated calibration and integrated quality control to ensure high sensitivity and accuracy comparable to centralized laboratory systems. Additionally, the analyzer includes a user-friendly interface and delivers test results within minutes, making it highly suitable for emergency departments, clinics, and decentralized healthcare environments.

In August 2024, Roche acquired LumiraDx point-of-care technology assets for an undisclosed amount. Through this acquisition, Roche aims to strengthen its diagnostics portfolio by integrating LumiraDx's innovative point-of-care testing platform, which includes immunoassay-based diagnostic capabilities, and expanding its presence in decentralized healthcare solutions. LumiraDx is a UK-based diagnostics company specializing in rapid point-of-care testing technologies.

Major companies operating in the point of care (poc) immunoassay analyzer expansion market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation, Becton, Dickinson and Company (BD), Beckman Coulter, Bruker Corporation, BioRad Laboratories, Qiagen N. V., Diasorin, Lepu Medical Technology, SD Biosensor, Eiken Chemical Co. Ltd., Molbio Diagnostics Pvt. Ltd., Maccura Biotechnology Co. Ltd., QuantuMDx Group Ltd., Ustar Biotechnologies Ltd., Mylab Discovery Solutions Pvt Ltd., Akonni Biosystems Inc., Zeesan Biotech Co. Ltd.

North America was the largest region in the point-of-care immunoassay analyzer expansion market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care (POC) immunoassay analyzer expansion market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the point of care (POC) immunoassay analyzer expansion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The point-of-care immunoassay analyzer expansion market consists of revenues earned by entities by providing services such as analyzer installation, calibration, maintenance, cloud-based data connectivity, software integration, remote monitoring, and consumable supply services. The market value also includes the value of related goods sold by the service provider or included within the service offering. The point-of-care immunoassay analyzer expansion market also includes sales of POC immunoassay analyzers, peripheral devices, biosensors, handheld analyzers, automated test systems, sample preparation devices, and associated accessories. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream healthcare providers, distributors, or retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point Of Care (POC) Immunoassay Analyzer Expansion Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses point of care (poc) immunoassay analyzer expansion market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point of care (poc) immunoassay analyzer expansion ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point of care (poc) immunoassay analyzer expansion market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Portable Analyzers; Benchtop Analyzers; Microfluidic Analyzers
• 2) By Technology: Chemiluminescence; Enzyme-Linked Immunosorbent Assay; Lateral Flow Assay
• 3) By Sample Type: Blood; Urine; Saliva
• 4) By Application: Infectious Diseases; Hormonal Testing; Autoimmune Disorders; Cardiac Markers; Oncology
• 5) By End User: Hospitals; Diagnostic Laboratories; Home Care Settings; Academic Research Institutions
• Subsegments:
• 1) By Portable Analyzers: Handheld Immunoassay Analyzers; Battery Operated Diagnostic Analyzers; Wireless Connected Portable Analyzers; Single Test Portable Analyzers; Multi Test Portable Analyzers
• 2) By Benchtop Analyzers: Compact Laboratory Benchtop Analyzers; High Throughput Benchtop Analyzers; Fully Automated Benchtop Analyzers; Semi Automated Benchtop Analyzers; Multi Assay Benchtop Systems
• 3) By Microfluidic Analyzers: Lab On A Chip Analyzers; Cartridge Based Microfluidic Analyzers; Continuous Flow Microfluidic Systems; Droplet Based Microfluidic Analyzers; Integrated Microfluidic Diagnostic Systems
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific; Abbott Laboratories; Siemens Healthineers AG; Danaher Corporation; Becton; Dickinson and Company (BD); Beckman Coulter; Bruker Corporation; BioRad Laboratories; Qiagen N.V.; Diasorin; Lepu Medical Technology; SD Biosensor; Eiken Chemical Co. Ltd.; Molbio Diagnostics Pvt. Ltd.; Maccura Biotechnology Co. Ltd.; QuantuMDx Group Ltd.; Ustar Biotechnologies Ltd.; Mylab Discovery Solutions Pvt Ltd.; Akonni Biosystems Inc.; Zeesan Biotech Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Point Of Care (POC) Immunoassay Analyzer Expansion Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Point Of Care (POC) Immunoassay Analyzer Expansion Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Artificial Intelligence & Autonomous Intelligence
  • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Industry 4.0 & Intelligent Manufacturing
• 4.2. Major Trends
  • 4.2.1 Expansion Of Decentralized Point-Of-Care Diagnostic Ecosystems
  • 4.2.2 Increasing Adoption Of Multiplex Immunoassay Platforms
  • 4.2.3 Integration Of Wireless Connectivity In Portable Analyzers
  • 4.2.4 Growth Of Cartridge-Based Rapid Testing Systems
  • 4.2.5 Rising Demand For At-Home Immunodiagnostic Solutions

5. Point Of Care (POC) Immunoassay Analyzer Expansion Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Diagnostic Laboratories
• 5.3 Home Care Settings
• 5.4 Academic Research Institutions
• 5.5 Other End Users

6. Point Of Care (POC) Immunoassay Analyzer Expansion Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Point Of Care (POC) Immunoassay Analyzer Expansion Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Point Of Care (POC) Immunoassay Analyzer Expansion PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Point Of Care (POC) Immunoassay Analyzer Expansion Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Point Of Care (POC) Immunoassay Analyzer Expansion Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Point Of Care (POC) Immunoassay Analyzer Expansion Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Point Of Care (POC) Immunoassay Analyzer Expansion Market Segmentation

• 9.1. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Portable Analyzers, Benchtop Analyzers, Microfluidic Analyzers
• 9.2. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Chemiluminescence, Enzyme-Linked Immunosorbent Assay, Lateral Flow Assay
• 9.3. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Blood, Urine, Saliva
• 9.4. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Infectious Diseases, Hormonal Testing, Autoimmune Disorders, Cardiac Markers, Oncology
• 9.5. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Diagnostic Laboratories, Home Care Settings, Academic Research Institutions
• 9.6. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Sub-Segmentation Of Portable Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Handheld Immunoassay Analyzers, Battery Operated Diagnostic Analyzers, Wireless Connected Portable Analyzers, Single Test Portable Analyzers, Multi Test Portable Analyzers
• 9.7. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Sub-Segmentation Of Benchtop Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Compact Laboratory Benchtop Analyzers, High Throughput Benchtop Analyzers, Fully Automated Benchtop Analyzers, Semi Automated Benchtop Analyzers, Multi Assay Benchtop Systems
• 9.8. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Sub-Segmentation Of Microfluidic Analyzers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lab On A Chip Analyzers, Cartridge Based Microfluidic Analyzers, Continuous Flow Microfluidic Systems, Droplet Based Microfluidic Analyzers, Integrated Microfluidic Diagnostic Systems

10. Point Of Care (POC) Immunoassay Analyzer Expansion Market Regional And Country Analysis

• 10.1. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 11.1. Asia-Pacific Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 12.1. China Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 13.1. India Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 14.1. Japan Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 15.1. Australia Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 16.1. Indonesia Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 17.1. South Korea Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 18.1. Taiwan Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 19.1. South East Asia Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 20.1. Western Europe Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 21.1. UK Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 22.1. Germany Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 23.1. France Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 24.1. Italy Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 25.1. Spain Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 26.1. Eastern Europe Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 27.1. Russia Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 28.1. North America Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 29.1. USA Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 30.1. Canada Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 31.1. South America Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 32.1. Brazil Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 33.1. Middle East Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Point Of Care (POC) Immunoassay Analyzer Expansion Market

• 34.1. Africa Point Of Care (POC) Immunoassay Analyzer Expansion Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Point Of Care (POC) Immunoassay Analyzer Expansion Market, Segmentation By Product Type, Segmentation By Technology, Segmentation By Sample Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Point Of Care (POC) Immunoassay Analyzer Expansion Market Regulatory and Investment Landscape

36. Point Of Care (POC) Immunoassay Analyzer Expansion Market Competitive Landscape And Company Profiles

• 36.1. Point Of Care (POC) Immunoassay Analyzer Expansion Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Point Of Care (POC) Immunoassay Analyzer Expansion Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Point Of Care (POC) Immunoassay Analyzer Expansion Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Point Of Care (POC) Immunoassay Analyzer Expansion Market Other Major And Innovative Companies

• Becton Dickinson and Company (BD), Beckman Coulter, Bruker Corporation, BioRad Laboratories, Qiagen N.V., Diasorin, Lepu Medical Technology, SD Biosensor, Eiken Chemical Co. Ltd., Molbio Diagnostics Pvt. Ltd., Maccura Biotechnology Co. Ltd., QuantuMDx Group Ltd., Ustar Biotechnologies Ltd., Mylab Discovery Solutions Pvt Ltd., Akonni Biosystems Inc.

38. Global Point Of Care (POC) Immunoassay Analyzer Expansion Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Point Of Care (POC) Immunoassay Analyzer Expansion Market

41. Point Of Care (POC) Immunoassay Analyzer Expansion Market High Potential Countries, Segments and Strategies

• 41.1 Point Of Care (POC) Immunoassay Analyzer Expansion Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Point Of Care (POC) Immunoassay Analyzer Expansion Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Point Of Care (POC) Immunoassay Analyzer Expansion Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer